G Medical Innovations Holdings Ltd Announces Nasdaq Staff
Rehovot, Israel, Feb. 17, 2023 (GLOBE NEWSWIRE) -- G Medical Innovations Holdings Ltd. (Nasdaq: GMVD) (the “Company”) announced today that on February 16, 2023, the Company received notice from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) that, based upon the Company’s non-compliance with the stockholders’ equity requirement for continued listing on The Nasdaq Capital Market, as set forth in Nasdaq Listing Rule 5550(b) (the “Equity Rule”), the Company is subject to delisting from Nasdaq unless the Company timely requests a hearing before a Nasdaq Hearings Panel (the “Panel”). Accordingly, the Company plans to timely request a hearing before the Panel, which will stay any delisting or suspension action pending the hearing and the expiration of any additional extension period granted by the Panel following the hearing.
As a separate matter, the Company was cited for providing material misrepresentations to the Staff, pursuant to Nasdaq Listing Rule 5250(a)(1), in relation to the Company’s Extraordinary General Meeting of shareholders, which was adjourned on February 9, 2023 and ultimately held and concluded on February 16, 2023. The Company originally believed and communicated to the Staff that it had met the quorum requirement on February 9, 2023 and believed that an adjournment would not be necessary. A quorum was present at the February 16, 2023 adjourned meeting and the shareholders of the Company voted upon and approved all agenda items that were described in the Company’s Notice and Proxy Statement for the meeting, which were included as Exhibit 99.1 to the Company’s Report of Foreign Private Issuer on Form 6-K that the Company furnished to the Securities and Exchange Commission on January 24, 2023.
About G Medical Innovations Holdings Ltd.:
G Medical Innovations Holdings Ltd. is a healthcare company engaged in the development of next generation mHealth and telemedicine solutions and monitoring service platforms. The Company’s solutions and services can empower consumers, patients, and providers to better monitor, manage and improve clinical and personal health outcomes, especially for those who suffer from cardiovascular disease (or CVD), pulmonary disease, and diabetes. The Company’s current product lines consist of its Prizma medical device (or Prizma), a clinical-grade device that can transform almost any smartphone into a medical monitoring device, enabling both healthcare providers and individuals to monitor, manage and share a wide range of vital signs and biometric indicators; its Extended Holter and Monitoring Cardiac Telemetry Patch services, utilizing a multi-channel patient-worn biosensors, with algorithms for real time analysis and transmission that captures electrocardiography (i.e. ECG) data continuously, including QT Syndrome Prolongation Detection. In addition, the Company is developing its Wireless Vital Signs Monitoring System (or VSMS), which is expected to provide full, continuous, and real-time monitoring of a wide range of vital signs and biometrics. Its monitoring services include provision of Independent Diagnostic Testing Facility (i.e., IDTF) monitoring services and private monitoring services.
In the second half of 2022, the Company expanded its business activities into a new business area, at-home laboratory testing kits. In the third quarter of 2023, the Company expects that users will be able to purchase a sample collection kit at retail stores or online and collect their sample from the comfort and privacy of their home and send it via mail to the Company’s certified lab for analysis. The Company has developed 31 types of tests kits which can test a wide range health issued related to hormones, sexual transferred disease, colon cancer, nutrition, food sensitivities and allergies. In addition, the Company’s pipeline includes development of additional kits for drug detection, heavy metal and toxicology. Data received from both vital signs and lab tests reflects the vision of the Company which is to allow users to create their personal electronic medical records and manage their health in one location which is available for them anywhere and anytime without dependency on any medical organization.
Visit https://gmedinnovations.com/.
Forward-Looking Statements:
This press release contains forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995 and other Federal securities laws. Words such as “expects,” “anticipates,” “intends,” “plans,” “believes,” “seeks,” “estimates,” and similar expressions or variations of such words are intended to identify forward-looking statements. For example, the Company is using forward-looking statements when it discusses: its plan to timely request a hearing before the Panel and that such request will stay any delisting or suspension action. The forward-looking statements contained or implied in this press release are subject to other risks and uncertainties. Except as otherwise required by law, the Company undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. References and links to websites have been provided as a convenience, and the information contained on such websites is not incorporated by reference into this press release.
Investors Relations Contact:
G Medical innovations Holdings Ltd.
service@gmedinnovations.com

TIN LIÊN QUAN
BBS-Bioactive Bone Substitutes: Approved delisting
BBS-Bioactive Bone Substitutes Oyj, Company release, 16 February 2023 at 7.45 pm EET BBS-Bioactive Bone Substitutes: Approved delisting application...
REE Automotive, Ltd. Announces Date for Fourth Quarter 2022
TEL-AVIV, Israel, March 09, 2023 (GLOBE NEWSWIRE) -- REE Automotive, Ltd. (NASDAQ: REE) (“REE” or the “Company”), an automotive technology company and...
NeuroMetrix, Inc. Announces Date for Fourth Quarter and
WOBURN, Mass., Feb. 16, 2023 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) announced today that it plans to issue its 2022 fourth quarter and year...
AFARAK SOUTH AFRICA (PTY) LTD - TERMINATION OF BUSINESS
08:30 London, 10:30 Helsinki, 23 February 2023 - Afarak Group SE ('Afarak' or 'the Company') (LSE: AFRK, NASDAQ: AFAGR) AFARAK SOUTH AFRICA (PTY) LTD -...
NCS Multistage Holdings, Inc. Schedules Fourth Quarter and
HOUSTON, Feb. 27, 2023 (GLOBE NEWSWIRE) -- NCS Multistage Holdings, Inc. (“NCS” or the “Company”) (Nasdaq: NCSM) will host a conference call to discuss...
Green Visor Financial Technology Acquisition Corp. I
SAN FRANCISCO, Feb. 09, 2023 (GLOBE NEWSWIRE) -- Green Visor Financial Technology Acquisition Corp. I (Nasdaq: GVCI) (the 'Company') announced today that...
THỦ THUẬT HAY
Tạo mật khẩu smartphone Android tự thay đổi mỗi giờ: Đố ai mở được khóa?
Trước hết, chúng ta cần tải phần mềm có tên là Screen Lock - Time Password trên Google Play.
Cách kiểm tra Macbook của bạn đang sử dụng chuẩn Wifi 802.11 nào
Thường thì chẳng mấy người dùng Mac quan tam đến việc Macbook của họ đang sử dụng chuẩn Wifi 802.11 nào. Tuy nhiên với những người dùng “cao” hơn một chút hay các Admin hệ thống mạng muốn biết chuẩn Wifi 802.11 nào
Cách tải video Youtube trực tiếp để xem ngoại mạng trên iPhone/iPad
Trước đây, để có thể xem video ngoại mạng trên ứng dụng Youtube, bạn phải sử dụng phiên bản YouTube Premium (Phải trả phí hàng tháng). Tuy nhiên, mới đây YouTube đã thử nghiệm mở tính năng này cho người dùng phổ thông
5 cài đặt ẩn tránh bị lạm dụng thông tin cá nhân trên Facebook
Sau vụ bê bối Cambridge Analytica, đã có rất nhiều cá nhân và tổ chức lớn tự xóa tài khoản của mình khỏi mạng xã hội Facebook nhằm phản đối việc để rò rỉ dữ liệu khoảng 50 triệu người dùng. Tuy nhiên, nếu bạn vẫn muốn
Các cách tra cứu mã số thuế chi tiết, đơn giản nhất hiện nay
Bạn đang muốn tra cứu mã số thuế nhưng vẫn chưa biết cách làm thế nào? Dưới đây là cách tra cứu mã số thuế vô cùng đơn giản bạn nên tham khảo. Cách tra cứu mã số thuế cá nhân đơn giản Cách 1: Tra cứu bằng website của
ĐÁNH GIÁ NHANH
Đánh giá OnePlus 5 - Chiếc điện thoại giống tất cả
Bản Oneplus 5 này đã thay đổi về quan điểm chiếc siêu điện thoại giá rẻ đến từ Trung Quốc này, xu hướng giống các siêu phẩm đang bị lạm dụng quá đà đã làm giảm sự húng thú của khách hàng.
Đánh giá Dell XPS 15 2-in-1: Mạnh mẽ, sang trọng, pin trâu
Laptop Dell XPS 2 in 1 không hẳn là một dòng máy tính mới (về cơ bản nó chính là Dell XPS) nhưng sự linh hoạt của nó giúp ích cho người dùng rất nhiều trong quá trình sử dụng hàng ngày. Bạn có thể sử dụng tại chỗ hoặc
Đánh giá Oppo F9: Ngoài camera selfie thì còn gì nữa?
OPPO F9 là chiếc smartphone tầm trung mới nhất vừa được giới thiệu với nhiều điểm nhấn hấp dẫn. Vậy ngoài danh tiếng camera selfie thì sản phẩm...